Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 4Classical hematology 2Breast 2Sarcoma 1Head & Neck 1Gynecologic 1Gastrointestinal 1

Conditions

Anemia, Refractory, with Excess of Blasts 27Leukemia, Myeloid, Acute 26Myelodysplastic Syndromes 21Venous Thromboembolism 13Myeloproliferative Disorders 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Neoplasms 11Lymphoma, Non-Hodgkin 10Leukemia, Myelomonocytic, Chronic 10Anemia 10Hematologic Neoplasms 9Primary Myelofibrosis 8Anemia, Aplastic 8Thrombocytopenia 7Leukemia, Lymphocytic, Chronic, B-Cell 7Hodgkin Disease 7Multiple Myeloma 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Leukemia 6Febrile Neutropenia 6Fanconi Anemia 6Congenital Bone Marrow Failure Syndromes 6Venous Thrombosis 5Pulmonary Embolism 5Myelodysplastic-Myeloproliferative Diseases 5Lymphoma, Follicular 5Recurrence 4Leukemia, Myeloid, Accelerated Phase 4Leukemia, Biphenotypic, Acute 4Cytopenia 4

Interventions

Tretinoin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pathologic Complete Response × Classical hematology × 90 days × Clear all
NCT07586813 2026-05-14

N01-A-PICIT-GI

Peking University People's Hospital

Phase 2 Recruiting
220 enrolled
Classical hematologyGastrointestinal

Pathologic Complete Response, Digestive System Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Thrombocytopenia, Colorectal Neoplasms

NCT07586826 2026-05-14

N01-A-PICIT-GT

Peking University People's Hospital

Phase 2 Recruiting
220 enrolled
BreastClassical hematologyGynecologicThoracic

Pathologic Complete Response, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Thrombocytopenia, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡